Literature DB >> 9085190

A rat model of distractibility: effects of drugs modifying dopaminergic, noradrenergic and GABAergic neurotransmission.

A Agmo1, C Belzung, C Rodríguez.   

Abstract

A procedure for analyzing effects of drugs on distractibility is proposed. Rats are trained to traverse a straight runway with a sucrose solution as reinforcement. Once the response has been acquired, an additional runway ending in an empty box is connected. The time spent investigating this additional runway is the measure of distractibility. Amphetamine, 1 mg/kg i.p., increased distractibility. In rats that were never reinforced, amphetamine at a dose of 1 mg/kg reduced the time spent in the additional runway. This shows that the effects of amphetamine in the reinforced animals cannot be interpreted as enhanced exploration. Furthermore, the benzodiazepines diazepam (2 and 4 mg/kg, i.p.) and chlordiazepoxide (2.5, 5 and 10 mg/kg, i.p.), known to enhance exploration of novel environments, did not affect the time spent in the additional runway in sucrose-reinforced animals. It was concluded that the procedure indeed is a model of distractibility. The dopamine antagonist cis(Z)-flupenthixol, at a dose of 0.25 mg/kg, i.p., blocked the effects of amphetamine, 1 mg/kg. Flupenthixol itself, in doses of 0.25 and 0.5 mg/kg, did not affect the time spent in the additional runway. This suggests that enhanced dopaminergic activity indeed is responsible for the effects. This proposal is further supported by experiments showing that the noradrenaline precursor dihydroxyphenylserine (10 mg/kg + carbidopa, 50 mg/kg, both i.p.) and the noradrenergic neurotoxin DSP4 (50 mg/kg, i.p.) had no effect on distractibility. Moreover, amfonelic acid, a dopamine releaser with slight or no effect on noradrenergic neurotransmission, had effects very similar to those of amphetamine when given in doses of 0.25 and 0.5 mg/kg, i.p. A lower dose, 0.125 mg/ kg, was ineffective. Taken together, these data suggest that enhanced dopaminergic neurotransmission increases distractibility in the rat. However, both amphetamine and amfonelic acid may stimulate serotonin release. Until serotonergic drugs have been tested, a contribution of this transmitter cannot be ruled out. The distraction procedure may constitute an animal model of some kinds of disordered information processing.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9085190     DOI: 10.1007/BF01271291

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  44 in total

1.  Antagonism of Low Dose Amphetamine Disruption of Latent Inhibition in Rats By Haloperidol, and By the 5Ht-3 Antagonist, Ondansetron: Warburton EC, Feldon J*, Weiner I*, Gray JA, Joseph MH MRC Brain, Behaviour and Psychiatry Research Group, Dept of Psychology, Institute of Psychiatry, London, SE5 8AF and *Dept of Psychology, University of Tel Aviv, Israel.

Authors: 
Journal:  J Psychopharmacol       Date:  1992-01       Impact factor: 4.153

2.  Latent inhibition is unaffected by direct dopamine agonists.

Authors:  J Feldon; A Shofel; I Weiner
Journal:  Pharmacol Biochem Behav       Date:  1991-02       Impact factor: 3.533

3.  Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain.

Authors:  S J Peroutka; D C U'Prichard; D A Greenberg; S H Snyder
Journal:  Neuropharmacology       Date:  1977-09       Impact factor: 5.250

4.  Attenuation of latent inhibition after compound pre-exposure: associative and perceptual explanations.

Authors:  R C Honey; G Hall
Journal:  Q J Exp Psychol B       Date:  1989-11

Review 5.  Dissociating learning and performance: drug and hormone enhancement of memory storage.

Authors:  J L McGaugh
Journal:  Brain Res Bull       Date:  1989 Oct-Nov       Impact factor: 4.077

6.  Different effects of amphetamine and amfonelic acid on peripheral and central catecholamine metabolism.

Authors:  S G Speciale; F Karoum; R J Wyatt
Journal:  Eur J Pharmacol       Date:  1980-04-04       Impact factor: 4.432

7.  Latent inhibition and blocking: further consideration of their construct validity as animal models of schizophrenia Commentary on Ellenbroek and Cools "Animal models with construct validity for schizophrenia"

Authors:  M.H. Joseph; S.H. Jones
Journal:  Behav Pharmacol       Date:  1991-12       Impact factor: 2.293

Review 8.  GABA and behavior: the role of receptor subtypes.

Authors:  R G Paredes; A Agmo
Journal:  Neurosci Biobehav Rev       Date:  1992       Impact factor: 8.989

9.  Reward and reinforcement produced by drinking sucrose: two processes that may depend on different neurotransmitters.

Authors:  A Agmo; A Galvan; B Talamantes
Journal:  Pharmacol Biochem Behav       Date:  1995-10       Impact factor: 3.533

10.  Dopamine and sexual behavior in the male rat: a reevaluation.

Authors:  A Agmo; H Fernández
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

View more
  2 in total

1.  Opposite effects of amphetamine on impulsive action with fixed and variable delays to respond.

Authors:  Scott J Hayton; Amanda C Maracle; Mary C Olmstead
Journal:  Neuropsychopharmacology       Date:  2011-10-05       Impact factor: 7.853

2.  D-amphetamine depresses visual responses in the rat superior colliculus: a possible mechanism for amphetamine-induced decreases in distractibility.

Authors:  J D Gowan; V Coizet; I M Devonshire; P G Overton
Journal:  J Neural Transm (Vienna)       Date:  2008-02-26       Impact factor: 3.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.